Company news
CalciMedica, Inc. news in 2026
CalciMedica, Inc.'s news releases, calls and decks from 2026, newest first.
CalciMedica Reports Third Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
November 10, 2026
CalciMedica to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
November 3, 2026
CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 8, 2026
CalciMedica Announces One-for-Five Reverse Stock Split
August 27, 2026
CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
August 11, 2026
CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints
July 29, 2026
CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program
June 24, 2026
CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data
June 24, 2026
CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
May 12, 2026
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates
March 2, 2026
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation
January 28, 2026
Decks in 2026
- Investor Presentation (November 2026)
Investor deck · 26 slides · November 2026
- Investor Presentation (June 2026)
Investor deck · 29 slides · Jun 24, 2026